Abbott India Limited
500488
ISIN INE358A01014 / Valor 561999
Abbott India Limited
UMushroom community rating:
About company
Abbott India Limited is the Indian subsidiary of Abbott Laboratories (NYSE: ABT), a global healthcare company headquartered in the United States. Abbott India is headquartered in Mumbai and manufactures and markets pharmaceutical formulations and consumer healthcare products in India. Key prescription brands include Udiliv (liver disease), Thyronorm (thyroid), Duphalac (laxative), and Creon (digestive enzyme). Key consumer brands include Digene (antacid), Cremaffin (laxative) and Peptazol. The company also has a diagnostics business. Revenue approximately ₹6,100 crore; high dividend payer. Listed on both BSE and NSE (ABBOTINDIA). A Nifty 500 constituent. Market capitalisation approximately ₹35,000–40,000 crore.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
6187 M
Market cap (USD)
626
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
